These drugs target some of the most pressing cancer types, including multiple myeloma, breast cancer, and bladder cancer ...

Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center, discusses some of the recent trends in cancer ...

During a live event, Xiuning Le, MD, PhD, discussed clinical trials of supportive care for infusion reaction and skin rash ...

Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, ...

When you are diagnosed with COPD, it is important to remember that you are not alone. A healthcare team, which may include a ...

Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L ...

With lung tumour cases on the rise in India, robotic-assisted thoracic surgery offers a breakthrough—providing faster ...

The presentation titled " Utilization of Proteomic Testing in Pulmonary Nodule Risk Stratification at a Safety-Net Hospital: ...

Amplia Therapeutics and Immutep have released clinical trial results that promise more effective treatments for pancreatic ...

Cancer survivor Cori Casebeer of Redding holds a sign supporting cancer research during the Hands Off! rally on April 5, 2025 ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is involved in lung repair and in ...